Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters








Database
Language
Publication year range
1.
J Vet Sci ; 23(6): e12, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36448431

ABSTRACT

BACKGROUND: Staphylococcus aureus and Streptococcus agalactiae are the main cause of clinical mastitis in dairy cattle in Argentina, whereas coagulase-negative staphylococci (CNS) and environmental streptococci are the main cause of subclinical mastitis. Bacteria isolated from infected animals show increasing antimicrobial resistance. OBJECTIVES: This study aims to determine the antimicrobial resistance of staphylococci and streptococci isolated from milk with mastitis, and to genotypically characterize the methicillin-resistant (MR) staphylococci. METHODS: Isolation was performed on blood agar and identification was based on biochemical reactions. Antimicrobial susceptibility was according to the Clinical and Laboratory Standards Institute guidelines. The antimicrobial resistance genes, SCCmec type and spa type were detected by the polymerase chain reaction method. RESULTS: We isolated a total of 185 staphylococci and 28 streptococci from 148 milk samples. Among the staphylococcal isolates, 154 were identified as CNS and 31 as S. aureus. Among the 154 CNS, 24.6% (n = 38) were resistant to penicillin, 14.9% (n = 23) to erythromycin, 17.5% (n = 27) to clindamycin, 6.5% (n = 10) to cefoxitin and oxacillin. Among the S. aureus isolates, 16.1% (n = 5) were resistant to penicillin, 3.2% (n = 1) to cefoxitin and oxacillin (MRSA). Six MR isolates (5 CNS and 1 MRSA) were positive to the mecA gene, and presented the SCCmec IVa. The MRSA strain presented the sequence type 83 and the spa type 002. Among the 28 streptococcal isolates, 14.3% (n = 4) were resistant to penicillin, 10.7% (n = 3) to erythromycin and 14.3% (n = 4) to clindamycin. CONCLUSIONS: The present findings of this study indicate a development of antimicrobial resistance in main bacteria isolated from cows with mastitis in Argentina.


Subject(s)
Cattle Diseases , Mastitis, Bovine , Female , Cattle , Animals , Staphylococcus , Anti-Bacterial Agents/pharmacology , Staphylococcus aureus , Cefoxitin , Clindamycin , Argentina/epidemiology , Drug Resistance, Bacterial , Mastitis, Bovine/epidemiology , Streptococcus , Oxacillin , Erythromycin
2.
Vet Anim Sci ; 7: 100043, 2019 Jun.
Article in English | MEDLINE | ID: mdl-32734065

ABSTRACT

This research communication describes the first isolation of a methicillin-resistant Staphylococcus aureus (MRSA) from cow's mastitic milk in Argentina. Bovine mastitis causes important economic losses in the dairy industry and the most commonly isolated bacteria from bovine mastitis are staphylococci. The mecA gene present in MRSA bacteria confers resistance to almost all ß-lactam antibiotics, the most frequent drugs used in bovine mastitis therapy.

3.
Curr Opin Pharmacol ; 31: 114-122, 2016 12.
Article in English | MEDLINE | ID: mdl-27889687

ABSTRACT

Chronic inflammation associated with obesity is now recognized to be an important condition in promoting carcinogenesis and progression in breast cancer patients, mostly in postmenopausal women with tumors expressing estrogen and progesterone receptors. In obese patients, altered levels of several inflammatory mediators regulating aromatase and estrogen expression are one of the mechanisms responsible of increase breast cancer risk. Growing attention has also been paid to the local adipose inflammation and the role played by macrophages as determinants of breast cancer risk recurrence and prognosis. The inflammation-obesity axis offers different molecular signaling pathways for therapeutic interventions and potential pharmacological targets. The increasing rate of obesity worldwide associated with the recent findings linking inflammation and breast cancer urge further investigation.


Subject(s)
Breast Neoplasms/etiology , Inflammation/pathology , Obesity/complications , Animals , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Chronic Disease , Disease Progression , Drug Design , Estrogens/metabolism , Female , Humans , Inflammation/complications , Inflammation/etiology , Inflammation Mediators/metabolism , Macrophages/metabolism , Receptors, Progesterone/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL